Protox Therapeutics Inc.
Box 1014, HSBC Building
885 West Georgia Street, Suite 1210
Vancouver
British Columbia
V6C 3E8
Canada
Tel: 604-688-0199
Fax: 604-688-0173
Website: http://www.protoxtherapeutics.com/
84 articles about Protox Therapeutics Inc.
-
Protox Therapeutics Inc. Announces Closing of Additional CDN $8.3 Million Investment by Warburg, Pincus Ventures, L.P.
12/28/2011
-
Protox Therapeutics Inc. Appoints Richard Yocum as Chief Medical Officer
12/12/2011
-
Protox Therapeutics Inc. Announces Move to San Diego and Senior Management Transition
4/18/2011
-
Protox Therapeutics Inc. Appoints Two New Directors
2/22/2011
-
Warburg, Pincus Ventures, L.P. to Invest $35 Million in Protox Therapeutics Inc.
9/30/2010
-
Protox Therapeutics Inc. Six-Month Prostate Drug Data Muted
6/2/2010
-
Protox Therapeutics Inc. Signs $75 Million License Agreement with Kissei Pharmaceutical Co., Ltd. for Commercialization of PRX302 in Japan for BPH and Prostate Disease
4/30/2010
-
Protox Therapeutics Inc. Reports 2009 Financial Results And Achievements
3/31/2010
-
Protox Therapeutics Inc. Reports Positive Phase2 Trial Results For Urological Drug
1/11/2010
-
Protox Therapeutics Inc. Reports 2009 Third Quarter Results
11/16/2009
-
Protox Therapeutics Inc. Presents Phase 2 BPH Data at the World Congress of the Société Internationale D'urologie
10/29/2009
-
Protox Therapeutics Inc. Completes Enrollment of Phase 2b BPH Trial
9/8/2009
-
Protox Therapeutics Inc. to Present Benign Prostatic Hyperplasia Data at Canadian Urology Conference
6/29/2009
-
Protox Therapeutics Inc. Appoints Dr. Alexander Giaquinto to Board of Directors
6/16/2009
-
Protox Therapeutics Inc. Presents BPH Data at the Annual American Urological Association Conference
4/29/2009
-
Protox Therapeutics Inc. Reports 2008 Financial Results and Achievements
3/27/2009
-
Protox Therapeutics Inc. Appoints John Parkinson Chief Financial Officer
3/23/2009
-
Protox Therapeutics Inc. Announces Positive Phase 2 BPH Results
11/24/2008
-
BTV-Business Television Features Protox Therapeutics Inc., Mercer International, and Alexis Minerals
10/23/2008
-
Protox Therapeutics Inc. Announces Positive 12 Month Data from BPH Study
10/8/2008